|
Hepalink Testing the waters
|
4
|
Resverlogix Corp.
|
Jun 06, 2015 02:08PM
|
|
Re: Presentation
|
4
|
Resverlogix Corp.
|
Oct 05, 2021 11:45AM
|
|
Re: Trial Status
|
4
|
Resverlogix Corp.
|
Jul 26, 2021 10:10AM
|
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
4
|
Resverlogix Corp.
|
Aug 15, 2022 09:40PM
|
|
Re: News !!!
|
4
|
Resverlogix Corp.
|
Feb 27, 2018 08:44PM
|
|
Crazy Question
|
4
|
Resverlogix Corp.
|
Jan 05, 2024 09:37AM
|
|
Re: Don't miss your chance - anyone interested in applying?
|
4
|
Resverlogix Corp.
|
Jul 06, 2022 12:45PM
|
|
Re: Funds
|
4
|
Resverlogix Corp.
|
Feb 19, 2023 10:57AM
|
|
Re: Cart...
|
4
|
Resverlogix Corp.
|
Jun 03, 2021 12:31PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
4
|
Zenith Epigenetics
|
Feb 19, 2022 01:23PM
|
|
Liquidity
|
4
|
Zenith Epigenetics
|
Jan 21, 2016 06:56PM
|
|
Re: The problem...as I see it
|
4
|
Resverlogix Corp.
|
Oct 16, 2020 06:56PM
|
|
Re: New MD&A posted
|
4
|
Resverlogix Corp.
|
Dec 17, 2019 10:41PM
|
|
Re: BETonMACE and Aminotransferases
|
4
|
Resverlogix Corp.
|
Aug 14, 2019 01:15PM
|
|
Re: New Zacks SCR report "Apabetalone: A Potential Alzheimer's Play?"
|
4
|
Resverlogix Corp.
|
Aug 24, 2018 02:39PM
|
|
Re: Phase III approval rates....
|
4
|
Resverlogix Corp.
|
Jul 12, 2015 03:08PM
|
|
Re: Another Week
|
4
|
Resverlogix Corp.
|
Oct 21, 2022 07:05PM
|
|
Re: ABCA1 overexpression worsens colorectal cancer prognosis and this can be ameliorated by apabetalone
|
4
|
Resverlogix Corp.
|
Aug 24, 2018 02:53PM
|
|
Re: TLD Confidence
|
4
|
Resverlogix Corp.
|
Aug 27, 2019 02:27PM
|
|
Re: Globe - Lessons from accelerated vaccine development - May 25, 2021
|
4
|
Resverlogix Corp.
|
May 27, 2021 07:08PM
|
